|1.||Kane, Janice D: 1 article (06/2012)|
|2.||Hubbard, Todd A: 1 article (06/2012)|
|3.||Feldman, Steven R: 1 article (04/2003)|
|4.||Sam, Maria C: 1 article (04/2003)|
|5.||Fleischer, Alan B: 1 article (04/2003)|
|6.||Gibbs, Trevor S: 1 article (04/2003)|
|7.||O'Donovan, Cormac A: 1 article (04/2003)|
|8.||Smith, T R: 1 article (04/2001)|
|9.||Klapper, J A: 1 article (04/2001)|
|10.||Gallagher, R M: 1 article (04/2001)|
|1.||Migraine Disorders (Migraine)
01/01/1976 - "Treatment of migraine with isometheptene, acetaminophen, and dichloralphenazone combination: a double-blind, crossover trial."
04/01/2001 - "Both isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate are safe and effective when used early in the treatment of an acute migraine. "
04/01/2001 - "This was a multicenter, double-blind, randomized, parallel-group study to assess the safety and efficacy of the combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the early stages of a single migraine attack. "
04/01/2001 - "Several parameters suggest that isometheptene mucate, dichloralphenazone with acetaminophen may have a slight advantage compared with sumatriptan succinate in the early treatment of mild-to-moderate migraine."
04/01/2001 - "The Food and Drug Administration approved sumatriptan succinate and the combination of isometheptene mucate, dichloralphenazone with acetaminophen for the treatment of migraine. "
|3.||Anaphylaxis (Anaphylactic Shock)
05/01/1998 - "To describe a patient who developed reversible segmental cerebral arterial vasospasm and cerebral infarction while taking excessive amounts of sumatriptan succinate and a combination drug (Midrin) consisting of isometheptene mucate, 65 mg, dichloralphenazone, 100 mg, and acetaminophen, 325 mg. Case report. "
|5.||Caffeine (No Doz)
|6.||Aspirin (Acetylsalicylic Acid)